Based on this information, ASPR will pause any further allocations of bamlanivimab and etesevimab together, etesevimab alone, and REGEN-COV pending updated data from the CDC. Shipments of sotrovimab did resume this week, and delivery of 55,000 doses of product has begun. An additional 300,000 doses of sotrovimab will be available for distribution in January.
This notice came out the day after my wife got the bamlanivimab/etesevimab.(Eli Lily)
In our case, I'm not concerned because I'm not worried about Omicron and only got the infusion for the wife in case we had Delta. Judging by our symptoms, I think we have Omicron.
Fatigue
Headache
Other body aches (including lower back pain)
Sore or “scratchy” throat
Runny nose
Sneezing
Of course since she got the monoclonal and I'm taking IVM and we're both taking the Zelenko/FLCCC protocol vitamins, I suppose it could be delta made mild by our early treatment.
one of the signatures of Omi is night sweats, bad night sweats, so watch for that and don’t get dehydrated :)
I’m no longer a fan of IVM since monoclonals were made publically available in 2021 and they work great with no guesswork on dosing. But if you take IVM, realize there are 78 identified drug interactions to watch for which may affect medication you’re already taking or affect how the disease is treated in hospital if it ever comes to that, which I hope it doesn’t:
https://www.drugs.com/drug-interactions/ivermectin-index.html?filter=2
Good luck.